ALREX: payments to doctors
Payments that named ALREX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $193K
- Providers
- 3,181
- Transactions
- 7,437
- Average per transaction
- $26
The per-transaction average — $26 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,181 providers the average total is $61, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $147,543 | 76.4% |
| Bausch & Lomb Americas Inc. | $45,411 | 23.5% |
| PBG Puerto RICO LLC | $20 | 0.0% |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $14 | 0.0% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $5 | 0.0% |
| Pfizer | $3 | 0.0% |